Teva Pharmaceutical reported 2.44B in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aspen Pharmacare APN:SJ 9.79B 2.7B
Guangzhou Baiy 600332:CH CH 20.97B 722.35M
Jiangsu Hengrui Me. 600276:CH CH 14.33B 1.9B
Kalbe Farma Tbk Pt KLBF:IJ RI 1916297.17M 1042847.35M
Richter Gedeon RICHT:HB 40.84B 50.61B
Sh Fosun Pharma 600196:CH CH 9.6B 1.52B
Teva Pharmaceutical TEVA:IT 2.44B 693M